ArticleBiotechnology and applied biochemistry2026
Polyethylene Carboxylates Synthesized via Statistical Optimization: A Biocompatible Polymer Scaffold for Bioactive Conjugation.
Article in Biotechnology and applied biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The study aimed to synthesize and evaluate polyethylene carboxylates (PECs) as a biocompatible polymer for drug delivery. The synthesis of PECs has been achieved by making slight modifications through statistical optimization in reaction conditions using the Jones reagent. The transformation has been confirmed by FTIR, NMR, and mass spectroscopy. The synthesized polymer was evaluated for its acute toxicity and ulcerogenic and hemolytic activity. The results revealed that PECs have successfully synthesized and have not shown any toxicity-related mortality. Moreover, PECs did not show any ulcerogenic and hemolytic activity, which was expected due to the presence of two carboxylic groups in the synthesized derivatives. The ease of performing the reaction and mild reagents make it the most suitable condition for synthesizing PECs. Biocompatibility (safety issues) regarding the employability of synthesized PECs has been tested, and the results have supported the same. The availability of the carboxylic group will open possibilities for the conjugation of bioactive compounds. This research work widens the scope for conjugation of most of the bioactive compounds and also proves to be an option for the linkers as they, by themselves, can be directly involved in the formation of polymer-drug conjugates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.